EKF Diagnostics Holdings ( (GB:EKF) ) has issued an update.
EKF Diagnostics Holdings plc has announced the buyback of 570,915 of its ordinary shares at a weighted average price of 21 pence per share, which will be held in treasury. This move is part of a strategic effort to manage the company’s share capital and maintain the aggregate indirect beneficial interest of key stakeholders, such as Mr. Mills, at a stable level. The buyback is expected to impact the company’s total voting rights, with the new total number of ordinary shares carrying voting rights being 451,539,956. This announcement reflects EKF’s ongoing commitment to optimizing its capital structure and ensuring compliance with regulatory requirements.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business focused on Point-of-Care analyzers in hematology and diabetes, as well as life sciences services that provide specialist manufacture of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling into over 120 countries worldwide.
YTD Price Performance: -22.22%
Average Trading Volume: 577,379
Technical Sentiment Signal: Strong Buy
Current Market Cap: £95.05M
See more data about EKF stock on TipRanks’ Stock Analysis page.